Table 3.
Correlation of IDHmut glioma patients’ characteristics with RPS27 mRNA expression.
| Patient Characteristics | Correlation Coefficient r | p-Value | Statistical Test |
|---|---|---|---|
| Sex (female/male) | n.d. | 0.676 | ANOVA |
| Age | 0.519 | <0.01 | Non-parametric correlation |
| OS | −0.214 | 0.294 | Non-parametric correlation |
| Growth pattern (usual/highly diffuse) |
n.d. | 0.520 | ANOVA |
Correlation of RPS27 mRNA expression with patients’ characteristics was examined by non-parametric tests (Spearman’s Rho). Expression differences were examined by ANOVA (ddCT-values, posthoc test: Scheffe procedure or Dunnet T3). Significant results are shown in bold. IDHmut glioma = isocitrate dehydrogenase mutant astrocytic tumor with the histological appearance of WHO grade II and III gliomas; OS = overall survival; n.d. = not determined.